Evidence map›Paper›PMID 28665541›Full record

ArticlePsycho-oncology2018

Feasibility of the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program for symptom improvement among breast cancer survivors.

Cecile A Lengacher, Richard R Reich, Sophia Ramesar, Carissa B Alinat, Manolete Moscoso, Lakeshia Cousin, Victoria R Marino, Maya N Elias, Carly L Paterson, Michelle L Pleasant and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psycho-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Effect of Psychological Intervention on Fear of Cancer Recurrence: A Systematic Review and Meta-Analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Cecile A LengacherCollege of Nursing, University of South Florida, Tampa, FL, USA.ORCID 0000-0003-2700-2367
Richard R ReichMoffitt Cancer Center and Research Institute, Tampa, FL, USA.
Sophia RamesarCollege of Nursing, University of South Florida, Tampa, FL, USA.
Carissa B AlinatCollege of Nursing, University of South Florida, Tampa, FL, USA.
Manolete MoscosoCollege of Nursing, University of South Florida, Tampa, FL, USA.
Lakeshia CousinCollege of Nursing, University of South Florida, Tampa, FL, USA.
Victoria R MarinoSchool of Aging Studies, University of South Florida, Tampa, FL, USA.
Maya N EliasCollege of Nursing, University of South Florida, Tampa, FL, USA.
Carly L PatersonNational Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Michelle L PleasantCollege of Nursing, University of South Florida, Tampa, FL, USA.
Carmen S RodriguezCollege of Nursing, University of South Florida, Tampa, FL, USA.
Hsiao-Lan WangCollege of Nursing, University of South Florida, Tampa, FL, USA.
Kevin E KipCollege of Public Health, University of South Florida, Tampa, FL, USA.
Hongdao MengSchool of Aging Studies, University of South Florida, Tampa, FL, USA.
Jong Y ParkMoffitt Cancer Center and Research Institute, Tampa, FL, USA.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
MBSR Symptom Cluster Trial for Breast Cancer SurvivorsR01CA131080 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI LENGACHER, CECILE A · 2009 to 2013
$2.7M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA131080
6 · The paper itself

Abstract

objectiveThe purpose of this pilot study was to test the feasibility of delivering the mobile mindfulness-based stress reduction for breast cancer (mMBSR(BC)) program using an iPad and to evaluate its impact on symptom improvement.

methodsA single group, pre-posttest design was implemented among female stages 0-III breast cancer survivors (BCS) who completed treatment. Data were collected at baseline and week 6 on measures of psychological and physical symptoms and quality of life. The mMBSR(BC) program is a standardized, stress-reducing intervention that combines sitting and walking meditation, body scan, and yoga and is designed to deliver weekly 2-hour sessions for 6 weeks using an iPad.

resultsThe mean age of the 15 enrolled BCS was 57 years; one participant was non-Hispanic black, and 14 were non-Hispanic white. Of the 13 who completed the study, there were significant improvements from baseline to 6 weeks post-mMBSR(BC) in psychological and physical symptoms of depression, state anxiety, stress, fear of recurrence, sleep quality, fatigue, and quality of life (P's < .05). Effect sizes for improvements of multiple symptoms ranged from medium to large.

conclusionsThese results provide preliminary support that the mMBSR(BC) program may be feasible and acceptable, showing a clinical impact on decreasing psychological and physical symptoms. This mobile-based program offers a delivery of a standardized MBSR(BC) intervention to BCS that is convenient for their own schedule while decreasing symptom burden in the survivorship phase after treatment for breast cancer.

Indexed as

AdultAnxietyBreast NeoplasmsCancer SurvivorsDepressionFatigueFemaleHumansMiddle AgedMindfulnessPilot ProjectsQuality of LifeStress, PsychologicalTreatment OutcomeYogabreast cancer survivorsMBSRmobile-basedquality of lifesymptom managment

Identifiers

PMID28665541
PMCPMC7771353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.